Methylxanthines in surgery: a bright future?
Methylxanthines have been used in clinical practice for over 100 years, and although understanding of their mechanisms of action is growing their effects are not fully understood. Nevertheless the knowledge to date has brought about a general upsurge of interest in methylxanthines and the development of novel derivatives. Methylxanthines are poised to escape the confines of their traditional role as these agents are applied in novel ways to surgical illnesses such as septic shock, the adult respiratory distress syndrome, cancer cachexia and functional neutrophil disorders. Methylxanthines, alone or in combination with other compounds, may well become part of the surgeon's future stock-in-trade.
Tuckey
J A
JA
Department of Surgery, University of Otago, Dunedin, New Zealand.
Parry
B R
BR
McCall
J L
JL
D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D012772:Shock, Septic / Q000188:drug therapy; D013514:Surgical Procedures, Operative / Q000639:trends; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use*; D014970:Xanthines / Q000494:pharmacology / Q000627:therapeutic use*
D014970:Xanthines; C008514:methylxanthine; D013806:Theophylline; D010431:Pentoxifylline